North American Molecular Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers North America Molecular Diagnostics Companies and it is Segmented by Technology (In-situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, PCR, and Other Technologies), Application (Infectious Disease, Oncology, Pharmacogenomics, Microbiology, Genetic Disease Screening, Human Leukocyte Antigen Typing, and Blood Screening), Product (Instrument, Reagent, and Other Products), End User (Hospitals, Laboratories, and Other End Users), and Geography (United States, Canada, and Mexico). The market provides the value (in USD million) for the above segments.

North American Molecular Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

North American Molecular Diagnostics Industry Overview

The North American molecular diagnostics market is moderately competitive due to the region's many local and global level companies. The international players in the market studied include Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Danaher Corporation (Cepheid Inc.), EXACT Sciences Corporation, F. Hoffmann-la Roche Ltd, Hologic Corporation, Illumina Inc., Myriad Genetics Inc., and Qiagen.

North American Molecular Diagnostics Market Leaders

  1. Abbott Laboratories

  2. Agilent Technologies

  3. Danaher Corporation (Cepheid Inc)

  4. F. Hoffmann-la Roche Ltd

  5. Hologic Corporation

  6. *Disclaimer: Major Players sorted in no particular order
North America Molecular Diagnostics Market.png

North American Molecular Diagnostics Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?